Tonix Pharma (TNXP) Announces 1st Participant in Military-Related PTSD Phase 3 Trial of TNX-102 SL

March 28, 2017 7:09 AM EDT Send to a Friend
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) announced today that it has enrolled the first participant in the Phase 3 HONOR ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login